results on tirzepatide Linearity of solution Weight loss results after 8

However, as research progressed, its therapeutic potential expanded beyond gastrointestinal applications

Frequent exposure of the esophagus to stomach acid can cause esophagitis, an inflammation of the esophagus that can lead to pain, ulcers, and difficulty swallowing

It is not a dosing recommendation

Some individuals choose this formulation to support hydration and overall wellness as part of a balanced lifestyle

In Phase 2 clinical trials, retatrutide was administered as a once-weekly subcutaneous injection, consistent with the delivery schedule used for existing approved therapies such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro)